vs
Side-by-side financial comparison of Cencora (COR) and Costco (COST). Click either name above to swap in a different company.
Cencora is the larger business by last-quarter revenue ($78.4B vs $67.3B, roughly 1.2× Costco). Costco runs the higher net margin — 3.0% vs 2.1%, a 0.9% gap on every dollar of revenue. On growth, Costco posted the faster year-over-year revenue change (8.3% vs 3.8%). Over the past eight quarters, Costco's revenue compounded faster (7.9% CAGR vs -0.4%).
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.
CostcoCOSTEarnings & Financial Report
Costco Wholesale Corporation, doing business as Costco, is an American multinational corporation which operates a chain of membership-only big-box warehouse club retail stores. As of 2021, Costco is the third-largest retailer in the world, and as of August 2024, Costco is the world's largest retailer of beef, poultry, organic produce, and wine, with just under a third of American consumers regularly shopping at Costco warehouses.
COR vs COST — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $78.4B | $67.3B |
| Net Profit | $1.6B | $2.0B |
| Gross Margin | 4.6% | 13.1% |
| Operating Margin | 1.5% | 3.7% |
| Net Margin | 2.1% | 3.0% |
| Revenue YoY | 3.8% | 8.3% |
| Net Profit YoY | 2.1% | 11.3% |
| EPS (diluted) | $8.40 | $4.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | $78.4B | — | ||
| Q1 26 | $85.9B | — | ||
| Q4 25 | $85.9B | $67.3B | ||
| Q3 25 | $83.7B | $86.2B | ||
| Q2 25 | $80.7B | $63.2B | ||
| Q1 25 | $75.5B | $63.7B | ||
| Q4 24 | $81.5B | $62.2B | ||
| Q3 24 | $79.1B | — |
| Q2 26 | $1.6B | — | ||
| Q1 26 | $566.1M | — | ||
| Q4 25 | $559.6M | $2.0B | ||
| Q3 25 | $-339.7M | $2.6B | ||
| Q2 25 | $687.4M | $1.9B | ||
| Q1 25 | $717.9M | $1.8B | ||
| Q4 24 | $488.6M | $1.8B | ||
| Q3 24 | $3.4M | — |
| Q2 26 | 4.6% | — | ||
| Q1 26 | 3.6% | — | ||
| Q4 25 | 3.6% | 13.1% | ||
| Q3 25 | 3.5% | 12.9% | ||
| Q2 25 | 3.6% | 13.0% | ||
| Q1 25 | 4.1% | 12.5% | ||
| Q4 24 | 3.1% | 12.9% | ||
| Q3 24 | 3.2% | — |
| Q2 26 | 1.5% | — | ||
| Q1 26 | 0.9% | — | ||
| Q4 25 | 0.9% | 3.7% | ||
| Q3 25 | 0.0% | 3.9% | ||
| Q2 25 | 1.1% | 4.0% | ||
| Q1 25 | 1.4% | 3.6% | ||
| Q4 24 | 0.9% | 3.5% | ||
| Q3 24 | 0.2% | — |
| Q2 26 | 2.1% | — | ||
| Q1 26 | 0.7% | — | ||
| Q4 25 | 0.7% | 3.0% | ||
| Q3 25 | -0.4% | 3.0% | ||
| Q2 25 | 0.9% | 3.0% | ||
| Q1 25 | 1.0% | 2.8% | ||
| Q4 24 | 0.6% | 2.9% | ||
| Q3 24 | 0.0% | — |
| Q2 26 | $8.40 | — | ||
| Q1 26 | $2.87 | — | ||
| Q4 25 | $2.87 | $4.50 | ||
| Q3 25 | $-1.74 | $5.87 | ||
| Q2 25 | $3.52 | $4.28 | ||
| Q1 25 | $3.68 | $4.02 | ||
| Q4 24 | $2.50 | $4.04 | ||
| Q3 24 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2B | $17.2B |
| Total DebtLower is stronger | $12.4B | — |
| Stockholders' EquityBook value | $3.6B | $30.3B |
| Total Assets | $81.7B | $82.8B |
| Debt / EquityLower = less leverage | 3.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | $2.2B | — | ||
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $17.2B | ||
| Q3 25 | $4.4B | $15.3B | ||
| Q2 25 | $2.2B | $14.8B | ||
| Q1 25 | $2.0B | $13.2B | ||
| Q4 24 | $3.2B | $11.8B | ||
| Q3 24 | $3.1B | — |
| Q2 26 | $12.4B | — | ||
| Q1 26 | $7.9B | — | ||
| Q4 25 | $7.9B | — | ||
| Q3 25 | $7.7B | — | ||
| Q2 25 | $8.2B | — | ||
| Q1 25 | $7.9B | — | ||
| Q4 24 | $8.1B | — | ||
| Q3 24 | $4.4B | — |
| Q2 26 | $3.6B | — | ||
| Q1 26 | $2.1B | — | ||
| Q4 25 | $1.9B | $30.3B | ||
| Q3 25 | $1.5B | $29.2B | ||
| Q2 25 | $2.0B | $27.1B | ||
| Q1 25 | $1.0B | $25.6B | ||
| Q4 24 | $226.6M | $24.5B | ||
| Q3 24 | $645.9M | — |
| Q2 26 | $81.7B | — | ||
| Q1 26 | $78.4B | — | ||
| Q4 25 | $78.4B | $82.8B | ||
| Q3 25 | $76.6B | $77.1B | ||
| Q2 25 | $74.0B | $75.5B | ||
| Q1 25 | $71.2B | $73.2B | ||
| Q4 24 | $69.1B | $73.4B | ||
| Q3 24 | $67.1B | — |
| Q2 26 | 3.45× | — | ||
| Q1 26 | 3.78× | — | ||
| Q4 25 | 4.15× | — | ||
| Q3 25 | 5.08× | — | ||
| Q2 25 | 4.16× | — | ||
| Q1 25 | 7.76× | — | ||
| Q4 24 | 35.96× | — | ||
| Q3 24 | 6.79× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $4.7B |
| Free Cash FlowOCF − Capex | — | $3.2B |
| FCF MarginFCF / Revenue | — | 4.7% |
| Capex IntensityCapex / Revenue | 0.4% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 2.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | $9.0B |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | — | ||
| Q1 26 | $527.9M | — | ||
| Q4 25 | $-2.3B | $4.7B | ||
| Q3 25 | $3.1B | $3.9B | ||
| Q2 25 | $109.2M | $3.5B | ||
| Q1 25 | $3.4B | $2.7B | ||
| Q4 24 | $-2.7B | $3.3B | ||
| Q3 24 | $1.0B | — |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-2.4B | $3.2B | ||
| Q3 25 | $2.9B | $1.9B | ||
| Q2 25 | $-74.0M | $2.3B | ||
| Q1 25 | $3.2B | $1.6B | ||
| Q4 24 | $-2.8B | $2.0B | ||
| Q3 24 | $818.1M | — |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -2.8% | 4.7% | ||
| Q3 25 | 3.4% | 2.2% | ||
| Q2 25 | -0.1% | 3.7% | ||
| Q1 25 | 4.3% | 2.5% | ||
| Q4 24 | -3.5% | 3.2% | ||
| Q3 24 | 1.0% | — |
| Q2 26 | 0.4% | — | ||
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.1% | 2.3% | ||
| Q3 25 | 0.3% | 2.3% | ||
| Q2 25 | 0.2% | 1.8% | ||
| Q1 25 | 0.2% | 1.8% | ||
| Q4 24 | 0.1% | 2.0% | ||
| Q3 24 | 0.2% | — |
| Q2 26 | — | — | ||
| Q1 26 | 0.93× | — | ||
| Q4 25 | -4.12× | 2.34× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | 0.16× | 1.82× | ||
| Q1 25 | 4.67× | 1.54× | ||
| Q4 24 | -5.56× | 1.81× | ||
| Q3 24 | 295.80× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COR
| U.S. Healthcare Solutions | $68.8B | 88% |
| International Healthcare Solutions | $7.6B | 10% |
| Other | $2.0B | 3% |
COST
| Foods And Sundries | $27.1B | 40% |
| Non Foods | $19.2B | 28% |
| Other | $12.1B | 18% |
| Fresh Foods | $9.9B | 15% |
| Membership | $1.4B | 2% |
